BioCentury
ARTICLE | Clinical News

TBC-CEA: Began a 50-patient Phase I/II study

July 6, 1993 7:00 AM UTC

Therion Biologics Corp. Product: TBC-CEA, live vaccinia virus cancer vaccine that contains the human gene for carcinoembryonic antigen Indication: Advanced gastrointestinal, breast or lung cancer St...